238 related articles for article (PubMed ID: 32217690)
1. Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells.
Jin C; Zhu X; Wu H; Wang Y; Hu X
J Biol Chem; 2020 May; 295(19):6425-6446. PubMed ID: 32217690
[TBL] [Abstract][Full Text] [Related]
2. Roles and mechanisms of phosphoglycerate kinase 1 in cancer.
Chen Y; Cen L; Guo R; Huang S; Chen D
Bull Cancer; 2022 Dec; 109(12):1298-1307. PubMed ID: 36096942
[TBL] [Abstract][Full Text] [Related]
3. The phosphoglycerate kinase 1 variants found in carcinoma cells display different catalytic activity and conformational stability compared to the native enzyme.
Fiorillo A; Petrosino M; Ilari A; Pasquo A; Cipollone A; Maggi M; Chiaraluce R; Consalvi V
PLoS One; 2018; 13(7):e0199191. PubMed ID: 29995887
[TBL] [Abstract][Full Text] [Related]
4. Perturbation of yeast 3-phosphoglycerate kinase reaction mixtures with ADP: transient kinetics of formation of ATP from bound 1,3-bisphosphoglycerate.
Geerlof A; Travers F; Barman T; Lionne C
Biochemistry; 2005 Nov; 44(45):14948-55. PubMed ID: 16274241
[TBL] [Abstract][Full Text] [Related]
5. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells.
Fukushi A; Kim HD; Chang YC; Kim CH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431
[TBL] [Abstract][Full Text] [Related]
6. Cryoenzymic studies on yeast 3-phosphoglycerate kinase. Attempt to obtain the kinetics of the hinge-bending motion.
Geerlof A; Schmidt PP; Travers F; Barman T
Biochemistry; 1997 May; 36(18):5538-45. PubMed ID: 9154937
[TBL] [Abstract][Full Text] [Related]
7. PGK1 : An Essential Player in Modulating Tumor Metabolism.
Duncan L; Shay C; Teng Y
Methods Mol Biol; 2022; 2343():57-70. PubMed ID: 34473315
[TBL] [Abstract][Full Text] [Related]
8. Highly potent bisphosphonate ligands for phosphoglycerate kinase.
Jakeman DL; Ivory AJ; Williamson MP; Blackburn GM
J Med Chem; 1998 Nov; 41(23):4439-52. PubMed ID: 9804684
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Glycolytic Enzyme PGK1 to Inhibit the Warburg Effect: A New Strategy for Keloid Therapy.
Wang P; Wang Q; Yang X; An Y; Wang J; Nie F; Pan B; Bi H; Qin Z
Plast Reconstr Surg; 2023 Jun; 151(6):970e-980e. PubMed ID: 36728674
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth.
Nie H; Ju H; Fan J; Shi X; Cheng Y; Cang X; Zheng Z; Duan X; Yi W
Nat Commun; 2020 Jan; 11(1):36. PubMed ID: 31911580
[TBL] [Abstract][Full Text] [Related]
11. Phosphoglycerate Kinases Are Co-Regulated to Adjust Metabolism and to Optimize Growth.
Rosa-Téllez S; Anoman AD; Flores-Tornero M; Toujani W; Alseek S; Fernie AR; Nebauer SG; Muñoz-Bertomeu J; Segura J; Ros R
Plant Physiol; 2018 Feb; 176(2):1182-1198. PubMed ID: 28951489
[TBL] [Abstract][Full Text] [Related]
12. Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1.
Wang S; Jiang B; Zhang T; Liu L; Wang Y; Wang Y; Chen X; Lin H; Zhou L; Xia Y; Chen L; Yang C; Xiong Y; Ye D; Guan KL
PLoS Biol; 2015; 13(9):e1002243. PubMed ID: 26356530
[TBL] [Abstract][Full Text] [Related]
13. Human acylphosphatase cannot replace phosphoglycerate kinase in Saccharomyces cerevisiae.
Van Hoek P; Modesti A; Ramponi G; Kötter P; van Dijken JP; Pron JT
Antonie Van Leeuwenhoek; 2001 Oct; 80(1):11-7. PubMed ID: 11761363
[TBL] [Abstract][Full Text] [Related]
14. Determining the quantitative relationship between glycolysis and GAPDH in cancer cells exhibiting the Warburg effect.
Zhu X; Jin C; Pan Q; Hu X
J Biol Chem; 2021; 296():100369. PubMed ID: 33545174
[TBL] [Abstract][Full Text] [Related]
15. Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes.
Ghashghaeinia M; Köberle M; Mrowietz U; Bernhardt I
Cell Cycle; 2019 Jun; 18(12):1316-1334. PubMed ID: 31154896
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.
Li X; Jiang Y; Meisenhelder J; Yang W; Hawke DH; Zheng Y; Xia Y; Aldape K; He J; Hunter T; Wang L; Lu Z
Mol Cell; 2016 Mar; 61(5):705-719. PubMed ID: 26942675
[TBL] [Abstract][Full Text] [Related]
17. Phosphoglycerate Kinase 1: An Effective Therapeutic Target in Cancer.
Qiu A; Wen X; Zou Q; Yin L; Zhu S; Sheng Y; He Y; Liu Q; Luo D; Guo Z
Front Biosci (Landmark Ed); 2024 Mar; 29(3):92. PubMed ID: 38538272
[TBL] [Abstract][Full Text] [Related]
18. Substrate-assisted movement of the catalytic Lys 215 during domain closure: site-directed mutagenesis studies of human 3-phosphoglycerate kinase.
Flachner B; Varga A; Szabó J; Barna L; Hajdú I; Gyimesi G; Závodszky P; Vas M
Biochemistry; 2005 Dec; 44(51):16853-65. PubMed ID: 16363799
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52.
Wang WL; Jiang ZR; Hu C; Chen C; Hu ZQ; Wang AL; Wang L; Liu J; Wang WC; Liu QS
Acta Pharmacol Sin; 2021 Apr; 42(4):633-640. PubMed ID: 32737469
[TBL] [Abstract][Full Text] [Related]
20. A sandwich ELISA for phosphoglycerate kinase.
Zhao W; Pao S; Malik F; Soh J; Fernandez S; Chirico WJ
J Immunoassay Immunochem; 2008; 29(3):220-33. PubMed ID: 18569371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
